Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.

Volume 202, 2017
Previous Article Next Article

Developing new platform chemicals: what is required for a new bio-based molecule to become a platform chemical in the bioeconomy?

Author affiliations


This paper proposes a framework with six dimensions that can be useful for evaluating the potential and the current stage of a bio-based platform chemical. The framework considers the technological and strategic challenges to be fulfilled by a company that intends to lead a platform based on a bio-based chemical. A platform chemical should be an intermediate molecule, with a structure able to generate a number of derivatives, that is produced at a competitive cost, capable of allowing exploitation of the scale and scope economies, and inserted within a complete innovation ecosystem that is able to create value with governance mechanisms that are capable of allowing coordination of the innovation process and facilitation of the value capture by the focal company leading the platform, in our case the producer of the platform molecule. Based on these six dimensions, three potential platform chemicals – succinic acid, butanol and farnesene – are compared and discussed. It is possible to identify important differences concerning the technological dimensions and the strategic dimensions as well. Two of the molecules – farnesene and succinic acid – adhere to most of the conditions required to structure a platform chemical. However, the innovation ecosystem is not complete and the governance mechanisms are still under development, so it is not clear if they will be capable of allowing a favorable position for value capture by the platform leader. Butanol structuring for a platform does not seem promising. The potential of the molecule is apparently not high and the strategic initiatives are in general not focused on innovation ecosystem structuring.

Back to tab navigation

Publication details

The article was received on 30 Jan 2017, accepted on 13 Mar 2017 and first published on 13 Mar 2017

Article type: Paper
DOI: 10.1039/C7FD00052A
Citation: Faraday Discuss., 2017,202, 213-225

  •   Request permissions

    Developing new platform chemicals: what is required for a new bio-based molecule to become a platform chemical in the bioeconomy?

    J. Bomtempo, F. Chaves Alves and F. de Almeida Oroski, Faraday Discuss., 2017, 202, 213
    DOI: 10.1039/C7FD00052A

Search articles by author